KB Home is set to report its Q3 2026 earnings on September 22, with analysts projecting a 45.3% drop in earnings per share to around $0.89 and a 20.2% decline in revenue to about $1.30 billion compared to last year. The consensus EPS estimate has recently been revised downward by 2.2%, signaling increased caution among analysts. Despite these challenges, KB Home maintains strong financial health, with a low debt-to-equity ratio of 0.53 and a high current ratio of 6.80, indicating solid liquidity and manageable debt levels. Investors will watch the report closely for signs of how the homebuilder is navigating a tough market environment.
KB Home's Q3 2026 earnings preview notes a projected 45.3% decline in EPS and a 20.2% drop in revenue compared to last year. For readers following the Consumer Cyclical sector, here is Pluang's market snapshot as of Sep 18, 2026 01:51 WIB: out of 105 priced US stocks, 67 rose and 36 fell. Notable movers include RENT at USD 1.88 with 8% Sell / 92% Buy order activity, GAP at USD 20.83 up 3.27%, and BBY at USD 94.47 up 3.26% with 0% Sell / 100% Buy order activity and a typical hold time of 64 days on Pluang.
Dayton T. Brown, Inc. inaugurated its new 104,000-square-foot Test & Qualification Center in Huntsville, Alabama, enhancing its capacity to support aerospace, defense, and propulsion programs. The facility's strategic location near Huntsville's aeros...
A new study by The Grossman Group reveals that while 60% of chief communications officers (CCOs) have influence at the leadership level, their communications functions lack the necessary systems, skills, and AI capabilities to fully meet their mandat...
More than 200 companies are actively developing over 240 Alzheimer's disease therapies, with around 20 drugs in late-stage trials and many others in earlier phases. Key players include Eli Lilly, Biogen, Johnson & Johnson, and Eisai, focusing on inno...
Sagimet Biosciences has initiated a crucial Phase 3 clinical trial in the U.S. for denifanstat, an oral treatment targeting moderate to severe acne. The trial, named AURORA, aims to enroll around 800 patients, including adolescents, to support regula...
Nokia reported third-quarter 2026 earnings per share of $0.10, surpassing the $0.08 estimate, and revenue of $5.78 billion, exceeding the $5.72 billion forecast. The company's AI and cloud sales surged 123%, driven by high demand for its IP Networks ...
